ImmunoHub ERA Chair holder

Workplace Instituto de Investigação e Inovação em Saúde
Date 05 February 2021
Location Porto, Portugal
Hours Full-time

The i3S Association merges three institutes and researchers from several schools of the University of Porto (UPorto), thus consolidating an extensive collaboration between all institutions spanning many years.

Despite the existence of an established critical mass studying Infection and Immunity at i3S, our research profile and visibility are modest at an international level. Furthermore, research in key areas of importance to the institute, such as Immune Development, Inflammation, Immunological Memory, Tumor Immunology, Immune Pathogenesis, is lacking. ImmunoHUB will be central to allow i3S to recruit a prominent scientist and team working in these topics and, therefore, close these gaps. By assembling an exceptional core team, ImmunoHUB aspires to develop an international platform of excellence and innovation in the field of Immunology in Porto.

As a highly relevant contributor to the advancement of the i3S strategy on Infection and Immunity, ImmunoHub is prepared to offer the conditions for the ERA Chair Holder and team to thrive:

 

  • 5-year contract as Research Coordinator, research equivalent to Full Professor
  • Group leader position at i3S
  • Human resources: salaries for 3 researchers, 2 technicians and 1 project manager
  • Laboratory space for up to 10 team members
  • €200.000 for small equipment
  • €200.000 start-up package
  • Temporary free access to i3S platforms
  • Allocated funds for meeting attendance and travelling
  • Allocated funds for relocation and support concerning housing, legal/immigration issues, spouse’s employment, kindergarten/schooling, etc

KEY DATES

Application opening/announcement: 1st February
Application deadline (preliminary): 31st May 2021
Results: no later than 31st July 2021
Estimated start date: September 2021

For further information, please see the i3S page here. Application form is open here.

Share

Like what you read? Share your thoughts!